X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5075) 5075
Publication (381) 381
Book Review (98) 98
Book Chapter (25) 25
Book / eBook (12) 12
Conference Proceeding (8) 8
Magazine Article (4) 4
Data Set (3) 3
Dissertation (3) 3
Newsletter (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3438) 3438
male (2259) 2259
index medicus (2156) 2156
female (1702) 1702
animals (1680) 1680
cardiac & cardiovascular systems (1447) 1447
middle aged (1290) 1290
aged (1056) 1056
heart failure (998) 998
atrial natriuretic factor - blood (960) 960
atrial fibrillation (868) 868
natriuretic peptides (813) 813
rats (763) 763
atrial-natriuretic-peptide (748) 748
pharmacology & pharmacy (737) 737
adult (695) 695
atrial natriuretic peptide (601) 601
heart failure - drug therapy (578) 578
risk factors (578) 578
heart (560) 560
hypertension (548) 548
atrial natriuretic factor - therapeutic use (540) 540
cardiology (487) 487
mortality (485) 485
heart failure - physiopathology (484) 484
heart-failure (441) 441
prognosis (437) 437
atrial natriuretic factor - metabolism (421) 421
treatment outcome (393) 393
care and treatment (390) 390
blood pressure - drug effects (388) 388
natriuretic peptide, brain - blood (370) 370
analysis (369) 369
biomarkers - blood (354) 354
physiology (354) 354
cardiovascular (353) 353
peptides (351) 351
atrial-fibrillation (343) 343
medicine & public health (335) 335
time factors (331) 331
blood pressure (326) 326
echocardiography (324) 324
atrial natriuretic factor - pharmacology (314) 314
hypertension - drug therapy (311) 311
peripheral vascular disease (309) 309
stroke (308) 308
mice (307) 307
brain natriuretic peptide (306) 306
congestive-heart-failure (304) 304
cardiac arrhythmia (296) 296
prospective studies (296) 296
research (296) 296
aged, 80 and over (293) 293
physiological aspects (286) 286
cardiac patients (275) 275
health aspects (272) 272
heart diseases (259) 259
medicine, general & internal (258) 258
hemodynamics - drug effects (257) 257
risk (257) 257
rodents (256) 256
heart failure - blood (255) 255
cardiovascular disease (250) 250
diagnosis (247) 247
rats, sprague-dawley (245) 245
renin - blood (242) 242
biomarkers (241) 241
angiotensin-converting enzyme inhibitors - therapeutic use (240) 240
abridged index medicus (238) 238
cardiovascular diseases (236) 236
hypertrophy (236) 236
atrial natriuretic factor - physiology (234) 234
blood-pressure (233) 233
medicine, research & experimental (233) 233
atrial natriuretic factor - genetics (231) 231
cardiovascular system (229) 229
disease (226) 226
myocardium - metabolism (226) 226
myocardial-infarction (224) 224
atrial natriuretic factor (219) 219
expression (218) 218
left-ventricular dysfunction (218) 218
atrial fibrillation - physiopathology (215) 215
atrial-natriuretic-factor (215) 215
acute myocardial-infarction (214) 214
hemodynamics (213) 213
prevention (211) 211
electrocardiography (208) 208
disease models, animal (206) 206
heart failure - diagnosis (201) 201
double-blind method (199) 199
medicine (199) 199
aldosterone - blood (198) 198
gene expression (197) 197
article (191) 191
surgery (190) 190
hypertension - physiopathology (188) 188
therapy (188) 188
drug therapy (187) 187
natriuretic peptide (187) 187
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4913) 4913
Japanese (58) 58
German (38) 38
Chinese (29) 29
Italian (18) 18
French (16) 16
Russian (11) 11
Spanish (9) 9
Polish (7) 7
Czech (3) 3
Portuguese (3) 3
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 20, pp. 1956 - 1964
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9597, pp. 1483 - 1493
Journal Article
The Lancet, ISSN 0140-6736, 07/2003, Volume 362, Issue 9380, pp. 316 - 322
Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological properties, have emerged as important candidates for... 
BETA-BLOCKER THERAPY | MEDICINE, GENERAL & INTERNAL | NEUROHORMONAL ACTIVATION | LEFT-VENTRICULAR DYSFUNCTION | IDIOPATHIC DILATED CARDIOMYOPATHY | PLASMA-LEVELS | N-TERMINAL PROATRIAL | ACUTE MYOCARDIAL-INFARCTION | CONGESTIVE-HEART-FAILURE | PROGNOSTIC VALUE | DIASTOLIC DYSFUNCTION | Recombinant Proteins - therapeutic use | Cardiovascular Diseases - physiopathology | Prognosis | Cardiovascular Diseases - drug therapy | Humans | Ventricular Dysfunction, Left - diagnosis | Biomarkers - blood | Heart Failure - drug therapy | Atrial Natriuretic Factor - physiology | Ventricular Dysfunction, Left - drug therapy | Atrial Natriuretic Factor - therapeutic use | Natriuretic Peptide, Brain | Heart Failure - diagnosis | Natriuretic Agents - therapeutic use | Cardiovascular Diseases - diagnosis | Physiological aspects | Care and treatment | Usage | Cardiovascular diseases | Biological markers | Natriuretic peptides | Cardiovascular disease | Hormones | Peptides | Medical diagnosis | Disease | Nervous system | Emergency medical care | Vasopeptidase | Peptide hormones | Dyspnea | Vasoactive agents | Rodents | Blood pressure | Heart diseases | Recombinant | Heart failure | Brain natriuretic peptide | Edema | Abnormalities | Bioassays | Pharmacology | Gene expression | Chemical compounds | Patients | Diagnostic software | Diagnostic systems | Ventricle
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2004, Volume 110, Issue 10, pp. 1231 - 1235
Background-Ischemia/reperfusion (I/R) injury complicates myocardial infarction and stroke by exacerbating tissue damage and increasing risk of mortality. We... 
Myocardial infarction | Endothelium-derived factors | Ischemia | Cardiovascular diseases | Natriuretic peptides | CELLS | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | POTASSIUM CHANNELS | myocardial infarction | REPERFUSION INJURY | cardiovascular diseases | ischemia | endothelium-derived factors | natriuretic peptides | SMOOTH-MUSCLE | ARTERIES | HYPERPOLARIZING FACTOR | PERIPHERAL VASCULAR DISEASE | VASODILATION | HEMATOLOGY | EXPRESSION | Rats, Wistar | Vasodilator Agents - therapeutic use | Endothelium, Vascular - drug effects | Male | Peptide Fragments - pharmacology | Natriuretic Peptide, C-Type - physiology | Myocardial Infarction - pathology | Atrial Natriuretic Factor - pharmacology | Drug Evaluation, Preclinical | Natriuretic Peptide, C-Type - pharmacology | Natriuretic Peptide, C-Type - therapeutic use | Ouabain - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Vasodilator Agents - pharmacology | Signal Transduction | Acetylcholine - pharmacology | Rats | Nitric Oxide - physiology | Barium - pharmacology | Receptors, Atrial Natriuretic Factor - physiology | Animals | Myocardial Infarction - drug therapy | Atrial Natriuretic Factor - therapeutic use | Endothelium, Vascular - secretion | Peptide Fragments - therapeutic use | Receptors, Atrial Natriuretic Factor - drug effects | Coronary Circulation - drug effects | Vasodilation - drug effects | Natriuretic Peptide, C-Type - secretion | Myocardial Reperfusion Injury - prevention & control
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 22, pp. 2070 - 2077
Journal Article
Journal Article